Medical Weight Loss for Altoona, Pennsylvania Residents

Altoona, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Altoona through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Follow-up that stays with you in Altoona: your care does not end at the first visit, Dr. Sharma and our team check in by secure video as you progress, no matter where you are in Pennsylvania. Results vary. Doctor review just $119 (medication separate).

Why Altoona Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Altoona a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Pennsylvania. That is the entire promise, and we keep it.

Altoona is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Altoona address.

For anyone in Altoona, Pennsylvania, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout downtown Altoona and the greater Blair County area of central Pennsylvania. We bill the $119 physician visit clearly and keep your medication billed separately, so the cost is transparent before anything ships to Pennsylvania.

Patients on the outskirts of Pennsylvania get the same flat pricing, the same physician, and the same fast start as those near the center of Altoona. Tirzepatide, which shares its active ingredient with Mounjaro and Zepbound, starts at $233 per month for Altoona patients and is billed apart from the $119 visit. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Altoona telehealth visits.

How Telehealth Works for Altoona

Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.

Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.

Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Altoona address in insulated cold-pack packaging.

Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .

Frequently Asked Questions, Altoona

Can people from Altoona get treated by New Hope Weight Loss?

Absolutely. We operate one physical clinic in Costa Mesa, California, and we provide telehealth care to Altoona, Pennsylvania. Whether you are in downtown Altoona and the greater Blair County area of central Pennsylvania or elsewhere in the area, the path is the same. Dr. Anjmun Sharma meets you by video and confirms if a compounded GLP-1 program is right for you.

Do Altoona patients ever have to come into the office?

Never. Care is delivered entirely through telehealth, which means Altoona residents stay home for consults, follow-ups, and questions. Once Dr. Sharma approves you, your compounded semaglutide or tirzepatide is mailed to Altoona inside cold-pack packaging that holds the right temperature in transit.

What is the cost breakdown for Altoona?

You pay $119 for the physician review. Semaglutide begins at $166 a month, or $499 across 90 days, and tirzepatide begins at $233 a month. Medication is a separate charge. We accept HSA, FSA, Klarna, and Affirm payments, and there is no distance surcharge applied to anyone in Altoona.

What areas of Altoona do you serve?

We serve patients from across Altoona by telehealth, including downtown Altoona and the greater Blair County area of central Pennsylvania.

Are there hidden fees for Altoona patients?

No. Altoona patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Altoona Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Altoona, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.